Skip to content
BidBenchmark

Contract award

MERLIN BIOTECH INC

SBIR FY25 CONCEPT AWARD, DEVELOPMENT OF AN IMMUNOTHERAPY FOR EWING SARCOMA USING A NOVEL MURINE MODEL
PIID
75N91025C00025
Award key
CONT_AWD_75N91025C00025_7529_-NONE-_-NONE-
Recipient UEI
U33SZN8R3966
Source as of
Current award value
$300,0003
Obligated to date
$300,0002
Potential with options
$300,0003
Awarding agency
Department of Health and Human ServicesNational Institutes of Health
Place of performance
Philadelphia, Pennsylvania
Set-aside
Small Business Set-Aside - Total
Pricing
Firm Fixed Price
Competition
Full and Open Competition after Exclusion of Sources55 offers received
Period of performance
Sep 22, 2025Sep 21, 2027Through Sep 21, 2027 if all options are exercised
Benchmark category
Unclassified

Transaction history

Every action recorded against this award, in the order the government reported them.

ModAction dateReasonObligationValue at action
0Sep 16, 2025Initial award$355,000.00$300,000.00
P00001Aug 20, 2026M-$55,000.00$300,000.00

Provenance

Which source record produced each displayed rollup figure.

FieldSourceFileRetrievedParserArtifact hash
awarding_agency_idUSAspending.govAug 22, 2026usaspending_contract_csv@2026.08.23d870b324656
contractor_idUSAspending.govAug 22, 2026usaspending_contract_csv@2026.08.23d870b324656
current_award_valueUSAspending.govAug 22, 2026usaspending_contract_csv@2026.08.23d870b324656
naics_codeUSAspending.govAug 22, 2026usaspending_contract_csv@2026.08.23d870b324656
potential_award_valueUSAspending.govAug 22, 2026usaspending_contract_csv@2026.08.23d870b324656
psc_codeUSAspending.govAug 22, 2026usaspending_contract_csv@2026.08.23d870b324656
total_obligatedUSAspending.govAug 22, 2026usaspending_contract_csv@2026.08.23d870b324656

Sources and method

Figures on this page are computed from public federal award records. Numbers are never estimated or generated; where a figure is withheld, the reason is stated rather than filled in.

This page is a record of one federal award, assembled from the transactions the government published against it. Note 1 describes where the rollup came from. Values are award values, not unit prices.

  1. 1Rollup values derive from 2 transaction records parsed from USAspending.gov, retrieved Aug 22, 2026 by transform awards@2026.08.1.
  2. 2Obligations are the sum of signed federal action obligations across all transactions; deobligations are negative and remain negative.
  3. 3Current and potential award values are taken from the latest reported action, not summed across modifications.